We are live on
!
Find out more
WVP
Worth Venture Partners Portfolio holdings
AUM
$31.6M
1-Year Est. Return
28.5%
This Fund
S&P 500
This Quarter
Est. Return
+5.78%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$202M
AUM Growth
-$20.4M
(-9.2%)
Cap. Flow
-$72M
Cap. Flow
% of AUM
-35.68%
Top 10 Holdings %
Top 10 Hldgs %
32.61%
Holding
161
New
27
Increased
32
Reduced
22
Closed
30
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Everspin Technologies
MRAM
|
+$3.23M |
| 2 |
Mirum Pharmaceuticals
MIRM
|
+$1.21M |
| 3 |
Lantronix
LTRX
|
+$1.2M |
| 4 |
SCYNEXIS
SCYX
|
+$920K |
| 5 |
Context Therapeutics
CNTX
|
+$872K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EMKR
Emcore Corp
EMKR
|
+$5.2M |
| 2 |
GRTX
Galera Therapeutics, Inc. Common Stock
GRTX
|
+$3.83M |
| 3 |
ADMS
Adamas Pharmaceuticals
ADMS
|
+$3.1M |
| 4 |
OIIM
02Micro International
OIIM
|
+$2.06M |
| 5 |
Aviat Networks
AVNW
|
+$1.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.09% |
| 2 | Healthcare | 11.1% |
| 3 | Financials | 3.75% |
| 4 | Consumer Discretionary | 3.07% |
| 5 | Real Estate | 1.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Silicon Motion
SIMO
$9.19B
| $7.98M | 3.95% |
83,972
+6,538
| +8% | +$493K |
|
2
PDF Solutions
PDFS
$2.13B
| $7.83M | 3.88% |
246,231
| – | – |
|
3
Photronics
PLAB
$1.79B
| $5.69M | 2.82% |
301,878
-29,791
| -9% | -$437K |
|
|
CYBE
4
DELISTED
Cyberoptics Corp
CYBE
| $5.42M | 2.69% |
116,566
| – | – |
|
5
Adtran
ADTN
$798M
| $4.6M | 2.28% |
201,309
+12,571
| +7% | +$254K |
|
|
DZSI
6
DELISTED
DZS Inc. Common Stock
DZSI
| $4.34M | 2.15% |
267,550
+46,058
| +21% | +$611K |
|
|
7
Everspin Technologies
MRAM
$354M
| $4.03M | 2% |
+356,722
| New | +$3.23M |
|
8
Silicom
SILC
$228M
| $3.26M | 1.62% |
63,202
+8,877
| +16% | +$394K |
|
|
9
SCYNEXIS
SCYX
$37M
| $3.01M | 1.49% |
61,591
+18,700
| +44% | +$920K |
|
|
10
Aviat Networks
AVNW
$262M
| $2.92M | 1.45% |
91,110
-47,864
| -34% | -$1.5M |
|
|
AVEO
11
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.74M | 1.36% |
585,168
+130,804
| +29% | +$811K |
|
|
PRTK
12
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $2.5M | 1.24% |
556,832
+167,392
| +43% | +$794K |
|
|
ENV
13
DELISTED
ENVESTNET, INC.
ENV
| $2.47M | 1.22% |
31,120
| – | – |
|
14
Hilton Grand Vacations
HGV
$3.84B
| $2.38M | 1.18% |
45,759
| – | – |
|
15
Carvana
CVNA
$43.3B
| $2.34M | 1.16% |
50,445
| – | – |
|
16
OneMain Financial
OMF
$6.9B
| $2.1M | 1.04% |
42,071
+5,095
| +14% | +$270K |
|
17
Franklin Covey
FC
$233M
| $2.09M | 1.04% |
45,176
+5,610
| +14% | +$249K |
|
|
THER
18
DELISTED
THERATECHNOLOGIES INC COM
THER
| $2.04M | 1.01% |
675,963
-32,084
| -5% | -$97K |
|
19
Raymond James Financial
RJF
$32.5B
| $1.92M | 0.95% |
19,077
| – | – |
|
20
Cardlytics
CDLX
$21M
| $1.81M | 0.9% |
2,744
+209
| +8% | +$160K |
|
|
FOCL
21
EDAP TMS S.A.
FOCL
$226M
| $1.68M | 0.83% |
279,956
-3,412
| -1% | -$19.8K |
|
|
SCPH
22
DELISTED
scPharmaceuticals
SCPH
| $1.67M | 0.83% |
332,647
+31,887
| +11% | +$175K |
|
23
Progressive
PGR
$124B
| $1.46M | 0.72% |
14,211
+1,169
| +9% | +$112K |
|
24
TechTarget
TTGT
$246M
| $1.38M | 0.69% |
14,464
-3,272
| -18% | -$308K |
|
25
A10 Networks
ATEN
$2.47B
| $1.38M | 0.68% |
83,129
+1,364
| +2% | +$20.7K |
|
Similar funds
VL
WTG
QCA
SP
OGC
PE
RL
AIIC
Worth Venture Partners's Q4 2021 Portfolio in Review
As of Q4 2021, Worth Venture Partners held 161 positions worth $202M, down 9.2% from $222M the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Worth Venture Partners withdrew a net $72M in Q4 2021, closing 30 positions and reducing 22 holdings. Its most notable exit was Galera Therapeutics, Inc. Common Stock, an estimated $3.83M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Worth Venture Partners opened a new position in Everspin Technologies worth $4.03M.
- Worth Venture Partners's largest Q4 2021 buy was Everspin Technologies: 356,722 shares worth $4.03M.
- Worth Venture Partners added most to SCYNEXIS in Q4 2021, an estimated $920K increase.
- Worth Venture Partners's biggest Q4 2021 reduction was Emcore Corp, cutting an estimated $5.2M.
- Worth Venture Partners fully exited Galera Therapeutics, Inc. Common Stock in Q4 2021, selling an estimated $3.83M.
- Worth Venture Partners's ten largest holdings make up 33% of its $202M portfolio in Q4 2021.
- Worth Venture Partners opened 27 new positions and closed 30 in Q4 2021.
- Worth Venture Partners's portfolio value fell 9.2% quarter-over-quarter to $202M.
Based on Worth Venture Partners's 13F filing for Q4 2021, filed 14 Feb 2022.